Genome-Wide PERV Inactivation in Pigs Using CRISPR/Cas9
- 434 Downloads
The shortage of organs for transplantation is probably the biggest unmet medical need. A potential problem with the clinical use of porcine xenografts is the risk that porcine endogenous retroviruses (PERVs) could infect human cells. In the past, we determined the PERV copy number in the porcine kidney epithelial cell line PK15 and in primary fibroblasts. Using CRISPR-Cas9, we disrupted the catalytic center of pol, which is essential for virus replication. Next, we isolated cells in which 100% of the PERV elements had been inactivated. This method enables the possibility of eradicating PERVs in vitro for application to pig-to-human xenotransplantation. Here we describe the methodological bases of this work.
Key wordsCRISPR Cas9 Xenotransplantation PERVs Pig genome editing
- 3.Schuurman H-J (2009) The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes—chapter 2: source pigs. Xenotransplantation 16:215–222. https://doi.org/10.1111/j.1399-3089.2009.00541.xCrossRefPubMedGoogle Scholar
- 16.Dunn D, DaCosta M, Harris M, Idriss R, O’Brien A (2015) Genetic modification of porcine endogenous retrovirus (PERV) sequences in cultured pig cells as a model for decreasing infectious risk in xenotransplantation. FASEB J 29:LB761Google Scholar